StockNews.com lowered shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research report released on Tuesday morning. Separately, Bank of America started coverage on Amphastar Pharmaceuticals in a research note on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]
Guidance Capital Inc Acquires 267 Shares of Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating Upgraded by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and PTC Therapeutics (NASDAQ:PTCT – Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Volatility and Risk Amphastar Pharmaceuticals has a […]
Guidance Capital Inc. purchased a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 6,885 shares of the company’s stock, valued at approximately $377,000. Other hedge funds and other institutional investors […]